WISEPENNY LTD

Company number 13821229 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

WISEPENNY LTD - Analysis Report

Company Number: 13821229

Analysis Date: 2025-07-29 15:23 UTC

Certainly, I will perform a detailed financial health assessment for Wisepenny Ltd based on the provided company data and accounts.


Financial Health Assessment for Wisepenny Ltd (as at 31 December 2023)

1. Financial Health Score: D

Explanation:
The company exhibits clear signs of financial distress, including persistent net current liability and negative net assets over the last three years. While it remains active and compliant with filings, the financial "vital signs" reveal symptoms of liquidity strain and undercapitalisation. This score reflects a concerning financial position but not yet insolvency, indicating urgent remedial action is needed to restore health.


2. Key Vital Signs

Metric 2023 Value Interpretation
Current Assets £26,883 Increased vs prior years, mostly cash. Good to have liquid resources but still insufficient.
Cash at Bank & in Hand £25,483 Significant cash increase, a "healthy pulse" of liquidity improving compared to prior years.
Current Liabilities £50,614 High short-term debts, primarily director loans, representing a "heavy burden" on cash flow.
Net Current Assets -£23,731 Negative working capital ("symptom of distress"), indicating inability to cover short-term debts.
Net Assets / Shareholders' Funds -£11,321 Negative equity ("chronic illness"), indicating liabilities exceed assets and accumulated losses.
Fixed Assets (Tangible) £12,410 Modest long-term assets; some depreciation noted, but not sufficient to offset liabilities.
Loans from Directors £49,414 Large and increasing director loans; reliance on insider funding to sustain operations.
Employee Count 1 Very small operation; limited scale may constrain revenue generation and resilience.

3. Diagnosis: Financial Condition and Underlying Health

  • Liquidity and Working Capital:
    The company exhibits a "weak pulse" in liquidity terms. Although cash increased substantially in 2023 (from £4,022 to £25,483), it is overshadowed by current liabilities of £50,614, mostly director loans. Negative net current assets of -£23,731 indicate insufficient short-term resources to meet obligations. This creates a risk of cash flow stress and potential payment delays to suppliers or creditors.

  • Capital Structure and Solvency:
    Net liabilities and negative shareholders’ funds (-£11,321) reflect accumulated losses and undercapitalisation. This "chronic imbalance" means the company’s debts exceed its assets, reducing creditor confidence and limiting borrowing capacity from external sources. Continued reliance on director loans suggests external financing access is constrained.

  • Profitability and Operations:
    Profit and loss reserves remain negative, and no profit figures are disclosed, indicating ongoing operational losses or at best break-even performance. With only one employee, operational scale is minimal, potentially limiting revenue and margin expansion.

  • Governance and Control:
    Directors are both shareholders and key creditors, which may align interests but also concentrates financial risk. The company remains compliant with filing deadlines and has not entered any formal distress status.


4. Recommendations: Steps to Improve Financial Wellness

  • Strengthen Working Capital:
    Aim to improve the cash conversion cycle by accelerating receivables, managing payables prudently, and controlling inventory levels. Explore short-term financing options or injections of equity capital to reduce reliance on director loans.

  • Formalise Director Loans:
    Consider converting some director loans into equity to improve balance sheet strength and reduce short-term repayment pressure.

  • Cost Control and Revenue Growth:
    Evaluate operational expenses critically and seek opportunities to increase sales volume or margins, particularly leveraging the online retail channel (SIC 47910).

  • Financial Monitoring and Forecasting:
    Implement regular cash flow forecasting and scenario planning to detect and address liquidity issues early, ensuring a "healthy heartbeat" in finances.

  • Seek Professional Advice:
    Engage with financial advisors or accountants for restructuring strategies and potential access to government grants or support schemes for small businesses.


Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 29 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.